These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

266 related items for PubMed ID: 1985197

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Strain specificity and binding affinity requirements of neutralizing monoclonal antibodies to the C4 domain of gp120 from human immunodeficiency virus type 1.
    Nakamura GR, Byrn R, Wilkes DM, Fox JA, Hobbs MR, Hastings R, Wessling HC, Norcross MA, Fendly BM, Berman PW.
    J Virol; 1993 Oct; 67(10):6179-91. PubMed ID: 7690420
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Neutralizing antibodies against the V3 loop of human immunodeficiency virus type 1 gp120 block the CD4-dependent and -independent binding of virus to cells.
    Valenzuela A, Blanco J, Krust B, Franco R, Hovanessian AG.
    J Virol; 1997 Nov; 71(11):8289-98. PubMed ID: 9343181
    [Abstract] [Full Text] [Related]

  • 8. V3 loop region of the HIV-1 gp120 envelope protein is essential for virus infectivity.
    Ivanoff LA, Dubay JW, Morris JF, Roberts SJ, Gutshall L, Sternberg EJ, Hunter E, Matthews TJ, Petteway SR.
    Virology; 1992 Apr; 187(2):423-32. PubMed ID: 1546447
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. V2 loop glycosylation of the human immunodeficiency virus type 1 SF162 envelope facilitates interaction of this protein with CD4 and CCR5 receptors and protects the virus from neutralization by anti-V3 loop and anti-CD4 binding site antibodies.
    Ly A, Stamatatos L.
    J Virol; 2000 Aug; 74(15):6769-76. PubMed ID: 10888615
    [Abstract] [Full Text] [Related]

  • 13. Replication and neutralization of human immunodeficiency virus type 1 lacking the V1 and V2 variable loops of the gp120 envelope glycoprotein.
    Cao J, Sullivan N, Desjardin E, Parolin C, Robinson J, Wyatt R, Sodroski J.
    J Virol; 1997 Dec; 71(12):9808-12. PubMed ID: 9371651
    [Abstract] [Full Text] [Related]

  • 14. Functional and immunologic characterization of human immunodeficiency virus type 1 envelope glycoproteins containing deletions of the major variable regions.
    Wyatt R, Sullivan N, Thali M, Repke H, Ho D, Robinson J, Posner M, Sodroski J.
    J Virol; 1993 Aug; 67(8):4557-65. PubMed ID: 8331723
    [Abstract] [Full Text] [Related]

  • 15. Expression and characterization of genetically engineered human immunodeficiency virus-like particles containing modified envelope glycoproteins: implications for development of a cross-protective AIDS vaccine.
    Rovinski B, Haynes JR, Cao SX, James O, Sia C, Zolla-Pazner S, Matthews TJ, Klein MH.
    J Virol; 1992 Jul; 66(7):4003-12. PubMed ID: 1602531
    [Abstract] [Full Text] [Related]

  • 16. Variable constraints on the principal immunodominant domain of the transmembrane glycoprotein of human immunodeficiency virus type 1.
    Merat R, Raoul H, Leste-Lasserre T, Sonigo P, Pancino G.
    J Virol; 1999 Jul; 73(7):5698-706. PubMed ID: 10364320
    [Abstract] [Full Text] [Related]

  • 17. Adaptation of human immunodeficiency virus type 1 to cells expressing a binding-deficient CD4 mutant (lysine 46 to aspartic acid).
    Choe HR, Sodroski J.
    J Virol; 1995 May; 69(5):2801-10. PubMed ID: 7707502
    [Abstract] [Full Text] [Related]

  • 18. Alteration of HIV-1 infectivity and neutralization by a single amino acid replacement in the V3 loop domain.
    Ivanoff LA, Looney DJ, McDanal C, Morris JF, Wong-Staal F, Langlois AJ, Petteway SR, Matthews TJ.
    AIDS Res Hum Retroviruses; 1991 Jul; 7(7):595-603. PubMed ID: 1768461
    [Abstract] [Full Text] [Related]

  • 19. Involvement of the V1/V2 variable loop structure in the exposure of human immunodeficiency virus type 1 gp120 epitopes induced by receptor binding.
    Wyatt R, Moore J, Accola M, Desjardin E, Robinson J, Sodroski J.
    J Virol; 1995 Sep; 69(9):5723-33. PubMed ID: 7543586
    [Abstract] [Full Text] [Related]

  • 20. Functional role of the V1/V2 region of human immunodeficiency virus type 1 envelope glycoprotein gp120 in infection of primary macrophages and soluble CD4 neutralization.
    Koito A, Harrowe G, Levy JA, Cheng-Mayer C.
    J Virol; 1994 Apr; 68(4):2253-9. PubMed ID: 8139010
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.